NASHVILLE, Tenn. Marcus Whitney stands out in Nashvilles health care sector as an investor in startups. In addition to co-founding a venture capital firm, hes organized an annual health tech conference and co-founded the citys professional soccer club.
And, often, hes the only Black man in the room.
So in summer 2020, as Black Lives Matter protesters filled city streets around the country following George Floyds murder, Whitney pondered the racial inequalities that are so obvious in his industry especially locally.
I sat at the intersection of two communities one that I was born into and one that I had matriculated into, he said.
On a quiet Sunday morning after the protests died down, he pounded out to his peers that pointed out those making the most money from Nashvilles for-profit health care industry are still almost all white men.
Whitney hit publish on Monday, leading to weeks of intense conversations.
The racial reckoning of the past couple of years has inspired many industries to take a look at their histories and practices. In health care, there are long-standing and in care for Black and white patients.
Those disparities have carried over into who gets funding for research and health startups. Of the nations more than health care and social assistance companies, which include home health and other health services, roughly or fewer than 4% are Black-owned, according to data from the U.S. Census Bureau.
Whitney wrote that this problem isnt his to fix, but he realized hes in a unique position as one of the few Black venture capitalists in health care. So his firm, Jumpstart Foundry, launched a dedicated fund to get behind Black entrepreneurs in health care. The letter was pretty key to pulling in investors, he said.
The fund is called . It’s a tiny slice of the estimated invested last year in health tech. But it did exceed its initial goal, raising of pharmaceutical giant Eli Lilly, medical supplier Cardinal Health, and the hospital chain that started Nashvilles health care industry, HCA.
Each corporation measures its annual profits in the billions of dollars, so the fund represents only a sliver of their investments. But Jumpstart is also just one part of their broader diversity investment initiatives. For example, Indianapolis-based Eli Lilly has committed $92 million to Black-led venture capital firms since December 2020, according to company spokesperson Carrie Martin Munk.
Whitney said he didnt have to convince those blue-chip firms that investing in Black founders was a wise move, but he did have to make the case that they would have enough promising startups from which to choose.
That was really emblematic of the fact that there was a disconnect between the communities. These investors simply did not know enough Black people to know whether or not there were enough deals out there, Whitney said. This is not like an indictment of them. This is the reality of our country.
Jumpstart Nova is the lead investor in three of the four companies its working with so far. That means Whitneys team scrutinizes the business plan, vouches for the founder, and draws up all the financial and legal documents so its easier for others to come along.
Its validation. You need someone to say, Were in, said Dr. , founder of San Francisco-based , one of the first startups to land a lead investment from Jumpstart Nova.
His firm is trying to streamline the process of commercializing promising cell therapies. Hundreds are in development, and of those, each is customized for a patient by using the patients own cells. The therapies target cancer, central nervous system diseases, or viruses. Cellevolve is partnering with academic medical centers and small biotech companies in an attempt to make the commercializing process more similar to how a pharmaceutical company shepherds a drug to market.
Marcus was one of the few investors that I spoke to that immediately got what were talking about, Porter said. He was like, This is either not going to work at all, or its going to be massive. Its nowhere in between.
Porter said his only discomfort has been feeling pressured at times to play the role of a Black entrepreneur with a hard-scrabble upbringing. Folks are looking for the story to tug on their heart strings, he said. But that wasnt my life.
He grew up in Compton, California, in a middle-class family, with a mother who is a nurse and a father in construction. I cant tell you this traumatic, inner-city, drama-filled narrative, said Porter, who has an M.D. and an MBA from the University of Pennsylvania.
Jumpstart is primarily looking for Black-led companies with untapped profit potential. But the venture funds backers also say they expect some startups will work on fixing health inequities.
One of the funds initial investments is in , which consolidates the medical records of people with autoimmune diseases particularly underrepresented people of color so their personal health data can more easily be included in scientific research.
Dr. , president of Meharry Medical College in Nashville, said he hopes some startups will work to ensure health inequities dont get worse, especially now that so many new companies in health care are built around using artificial intelligence. Hildreth said he fears what big data could do without Black representation in the decision-making process or as DrugViu is trying to resolve in the clinical data.
The people designing the algorithms can unconsciously sometimes into how the algorithms are designed and how they function, he said.
The historically Black medical school in 2021 to seek profitable activities that align with Meharrys mission of eliminating health disparities. Meharry has also invested in the Jumpstart Nova fund. Hildreth said he sees it as an opportunity to make money and to make a statement to students.
We believe enough in the ingenuity, the innovation, and the intelligence of folks who look like us that were willing to invest in them, Hildreth said. With the expectation that the companies that come out of this fund are going to have a huge impact, not just on our communities, but people in general.
This story is from a partnership that includesand KHN.
